Form 4: Eli Lilly Director Boosts Stake in Company

Eli Lilly & Co. Director Ralph Alvarez acquired additional common stock, increasing his direct beneficial ownership to 55,378.773 shares.

Summary

• Ralph Alvarez, a Director at Eli Lilly & Co. (LLY), acquired additional common stock on November 17, 2025.
• The transactions involved two acquisitions: 11.5 shares and 215.327 shares.
• The acquisition price for both transactions was $1,021.7 per share.
• Following these transactions, Alvarez's direct beneficial ownership increased to 55,378.773 shares.
• An additional 758 shares are indirectly beneficially owned by a Trust.
• The 11.5 shares were deferred as stock units under the Lilly Directors' Deferral Plan, to be settled in common stock upon his separation from service.

Sentiment

Score: 8

Explanation: The acquisition of additional shares by a director, especially at a high price, generally signals strong confidence in the company's future performance and valuation, which is a positive indicator for investors.

Positives

• A company director, Ralph Alvarez, increased his direct beneficial ownership in Eli Lilly & Co., signaling confidence in the company's future prospects.
• The acquisition of shares, including those deferred under a company plan, aligns the director's interests with those of shareholders.

Future Outlook

The filing indicates that 11.5 shares acquired as stock units will be settled in common stock following the reporting person's separation from service, representing a future commitment.

Management Comments

• At the election of the reporting person, the shares reported as acquired in this row have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Industry Context

This insider transaction is specific to Eli Lilly & Co. and does not directly reflect broader industry trends, though it occurs within the context of the pharmaceutical and biotechnology sector where executive compensation often includes equity components.

Corporate Governance

Related Party Transactions

• Director Ralph Alvarez acquired common stock from Eli Lilly & Co. as part of his compensation, including 11.5 shares deferred as stock units under the Lilly Directors' Deferral Plan in lieu of cash compensation.

Stakeholder Impact

• Shareholders: May view the director's increased stake as a positive signal of confidence in the company's future performance and value.

Next Steps

• Settlement of 11.5 deferred stock units into common stock shares upon Ralph Alvarez's separation from service.

Key Dates

Recommendation

The acquisition of additional common stock by a director, particularly through a deferral plan and direct purchase, indicates strong insider confidence in Eli Lilly & Co.'s future prospects and intrinsic value. Such insider buying often precedes positive company developments or reflects a belief that the stock is undervalued, making it a favorable signal for potential investors.

Keywords

Eli Lilly, LLY, Form 4, Insider Trading, Director Stock Acquisition, Beneficial Ownership, Pharmaceuticals, Biotech